Massimiliano Marinoni
Rome, 00133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.
Journal: Hematological oncology
Published: November 03, 2025
Sustained remission in relapsed/refractory diffuse large B cell lymphoma following Glofitamab discontinuation due to JC virus reactivation: balancing efficacy and infectious risk.
Journal: Current research in translational medicine
Published: June 30, 2025
Association of [18F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia.
Journal: Diagnostics (Basel, Switzerland)
Published: March 20, 2025
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression.
Journal: Biomedicines
Published: April 01, 2024
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study.
Journal: Annals of hematology
Published: March 14, 2024
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
Journal: Thrombosis research
Published: December 06, 2023
Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F.
Journal: Cancers
Published: January 12, 2023
Immunostimulants in respiratory diseases: focus on Pidotimod.
Journal: Multidisciplinary respiratory medicine
Published: May 24, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026